Importantly, we observed statistical differences in the plasma insulin and APO-B (apolipoprotein-B) parameters (p < 0.05) (Table 1) but not in the prevalence of all metabolic abnormalities among the four PCOS phenotypes (Table 2). This evidence concerns the gene INS and polycystic ovary syndrome.